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Abstract
Dental retentions have a high prevalence among the general population and their removal can involve multiple 
complications. The use of platelet rich plasma has been proposed in an attempt to avoid these complications, as 
it contains high growth factors and stimulates diverse biological functions that facilitate the healing of soft and 
hard tissues.
Objectives: To evaluate the available scientific evidence related to the application of platelet-rich plasma in the 
post-extraction alveoli of a retained lower third molars. 
Material and Methods: A systematic review of published literature registered in the Medline, EMBASE, Cochrane 
and NIH databases. The following categories were included: human randomized clinical studies. Key search words 
were: platelet rich plasma; platelet rich plasma and oral surgery; platelet rich in growth factors and third molar.  
Results: Of 101 potentially valid articles, seven were selected, of which four were rejected as they failed to meet 
quality criteria. Three studies fulfilled all selection and quality criteria: Ogundipe et al.; Rutkowski et al.; Haraji 
et al. The studies all measured osteoblast activity by means of sintigraphy, and also registered pain, bleeding, 
inflammation, temperature, numbness as perceived by the patients, radiological bone density and the incidence of 
alveolar osteitis.  
Conclusions: Scientific evidence for the use of PRP in retained third molar surgery is poor. For this reason rando-
mized clinical trials are needed before recommendations for the clinical application of PRP can be made. 
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Introduction
The use of platelet-rich plasma (PRP) is one recently 
proposed approach to managing complications in re-
tained/impacted lower third molar surgery. Various 
authors have described PRP as an effective means for 
improving the healing of both hard and soft tissues, 
resulting in reductions in pain, inflammation and tris-
mus, as well as an acceleration of the bone regeneration 
process. However, there is some controversy in the li-
terature, which might be due to differing protocols for 
obtaining PRP (centrifugation) and the low numbers of 
systematic studies carried out to date (1,2).
PRP contains high concentrations of growth factors that 
stimulate different biological functions such as chemo-
taxis, angiogenesis, cell proliferation and differentiation, 
all of which facilitate healing (1-3); so when the platelets 
release growth factors, they trigger a process of tissue 
regeneration. In addition to growth factors, granulation 
tissue in wounds treated with PRP contains intra- and 
extra-platelet components that could also contribute to 
tissue regeneration (4,5).
PRP presents a low risk of infection or immunological 
reactions, as the platelets play an important role in host 
defense mechanisms at the wound site, due to a signal 
peptide release that attracts macrophages. The antimi-
crobial activity of platelet concentrates on the various 
bacteria species involved in oral infection has also been 
cited (1-5).
Recently, several randomized clinical trials (RCT) have 
been performed with small sample sizes and short fo-
llow-up periods, which have shown the results of PRP 
application to third molar surgical sites in the short term 
(6-12). The aim of the present study was to evaluate the 
scientific evidence in support of PRP application to re-
tained lower third molar post-extraction alveoli.  
Material and Methods
*Bibliography Search 
A search was made for articles on platelet-rich plasma 
among the published biomedical literature included in 
the following databases: Medline (via Pubmed); EM-
BASE (via Ovid); NIH; and the Cochrane Central Re-
gister of Controlled Trials. The search was extended 
to include systematic literature reviews in the Medline 
database and the Cochrane Database of Systematic Re-
views. The search was limited to randomized clinical 
studies of human, regardless of study duration or the 
language of publication. 
*Search Strategy
The search covered all literature published up to and 
including June 30th 2013. The search parameters were 
“randomized clinical trials on humans”. The key search 
words used were: 
- In the Medline database: platelet-rich plasma and oral 
surgery; plasma rich in growth factors and third molar.
- In the EMBASE database: platelet rich plasma and 
oral surgery.
- In the Cochrane database: platelet rich plasma.
- In the NIH database: platelet rich plasma and oral 
surgery.
*Article Selection Criteria
-Inclusion criteria
Studies with the following characteristics were included:
Population: studies of humans that included adult pa-
tients who had undergone extractions of one or more 
retained lower third molars.  
Intervention: application of platelet-rich plasma to post-
extraction lower third molar alveoli.
Comparison: application of a placebo to post-extraction 
retained lower third molar.  
Result variables assessed: pain, inflammation, blee-
ding, degree of healing, incidence of alveolar osteitis, 
degree of radiological bone regeneration and osteoblast 
activity. 
Study design: only randomized clinical trials (RCTs) 
were included of parallel groups or split-mouth, one 
group having received an application of PRP and the 
other a placebo, with the two applications distributed 
randomly. 
-Exclusion criteria
- Articles dealing with platelet-rich plasma applications 
to extraction sites of teeth other than retained lower 
third molars. 
- Randomized clinical trials combining platelet-rich plas-
ma application with other bone regeneration materials.   
- Articles duplicating the same trial or study population 
as another, obtaining the same results, but using different 
study periods, or published in more than one journal. 
*Data extraction 
Relevant data were extracted from the studies that met 
the inclusion criteria and collated in tables of scientific 
evidence that registered the following data: 
- Authors and year of publication. 
- Study design: clinical trial of parallel groups or split 
mouth. 
- Patient selection criteria. 
- Sample size.
- Protocol for obtaining PRP.
- Initial patient characteristics.
- Result variables. 
Quality evaluation and synthesis of scientific evidence 
A critical assessment of the selected studies was per-
formed, evaluating their internal and external validity. 
This was done by means of the Jadad scale (13), which 
awards a score of zero to five according to whether or 
not the following criteria were met:
- Whether or not the study was randomized. 
- Whether or not it was double blind. 
- Whether or not it listed patients lost or retired from the 
study procedure. 
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- Whether or not the method for generating the rando-
mization sequence (if described) was adequate. 
According to the Jadad scale, a clinical trial is consi-
dered of poor quality if it scores less than three. On the 
basis of the information extracted and collated in tables 
of scientific evidence and having assessed the quality 
of the clinical trials, the evidence identified as being of 
adequate quality was then organized, synthesized, and 
structured.   
*Classification of scientific evidence 
The quality of scientific evidence was classified by 
means of the GRADE system (14). 
Results
1- Search Results. Flow diagram
a) Systematic reviews and meta-analyses
Five systematic reviews were found (1,2,5,15,16), all of 
which were excluded because: one (1) included clinical 
trials that had combined PRP with other bone regenera-
tion materials, and had applied these to not only retai-
ned lower third molar post-extraction alveoli; another 
review (15) included clinical studies in which bone 
defects were treated by means of periodontal defect 
regeneration or maxillary sinus elevation; two (2,16) 
analyzed the characteristics of platelet-rich plasma, te-
Author and year  
Sammartino 
et al. (6) 
Mozzati 
et al. (7)
Ogundipe
et al. (8) 
Célio-Mariano 
et al. (9) 
Gürbüzer
et al. (10)
Rutkowski
et al. (11) 
Haraji
et al. (12) 
Randomized study 1 1 1 1 1 1 1
Double blind 0 0 0 0 1 1 1
Study describes patients 
lost or retired 1 0 0 1 0 1 0
Method for generating 
randomization sequence 
described and found 
adequate
0 0 1 0 0 0 0
Adequate blinding 
conditions 0 0 0 0 1 1 1
Total 2 1 2 2 3 4 3
Table 1. Results of quality evaluation generated by the Jadad scale (13) for RCTs initially selected. 
chniques for obtaining it and its possible applications, 
rather than treating lower third molar sites; the last (5) 
did not fall within the field of oral surgery but applied 
PRP to chronic cutaneous wounds.    
b) Randomized clinical trials 
The search identified 101 articles, of which 16 were du-
plications. Of the remaining 85, 72 were discarded on 
the basis of the title, as it was clear that they did not 
correspond to the application of platelet rich plasma in 
retained lower third molar surgery. 
In this way, 13 articles were identified that were poten-
tially adequate for inclusion. Having reviewed the abs-
tracts, seven articles that met all the proposed inclusion 
criteria were selected and their complete texts were 
read; all were randomized clinical trials (6-12). 
After evaluating the quality and potential for bias by 
means of the Jadad scale (13), four were eliminated as 
they failed to achieve the minimum score required (6-9) 
(Table 1). Figure 1 is a flow diagram describing the RCT 
selection process.
2- Qualitative Synthesis 
The results extracted from the RCTs selected are shown 
in table 2.
Gürbüzer et al. (10) is a split-mouth study of 12 patients 
with bilateral retained lower third molars. The study ob-
jective was to investigate the short-term effects of PRP 
on osteoblast activity during the alveolar healing pro-
cess after retained mandibular third molar extraction. 
Osteoblast activity was measured in alveolar neoformed 
bone by means of scintigraphy, one and four weeks after 
surgery. 
16 ml of blood were extracted in two 8.5 ml tubes with 
citrate phosphate dextrose as anticoagulant; double-
centrifugation was performed, with an initial ten-minu-
te centrifugation at 2400 rpm and a final centrifugation 
at 3600 rpm for 15 minutes. The PRP obtained was di-
luted in saline solution at a concentration of 1:5. Lastly, 
the patients own blood and 0.5 ml of calcium chloride 
were added. 
Bone scintigraphy with technetium-99 was performed 
one and four weeks after surgery. No statistically signi-
ficant differences were found between groups. 
Rutkowski et al. (11) carried out a split-mouth study of 
six patients. Only non-smokers took part, who had bi-
lateral retained lower third molars in similar states of 
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Author and year  Gürbüzer (10) Rutkowski (11) Haraji 2012 (12) 
Pain (VAS) 
Day 1 N E N.D.P.  
Day 2 N.E. N.D.P. 
PRP group: mean 
= 2.77 
control group: 
mean = 3.97 
p < 0.00 
Day 3 N.E. N.D.P. 
PRP group: mean 
= 2.09  
control group: 
mean =3.82  
p < 0.00 
Day 4 N.E. N.D.P. 
PRP group: mean 
= 1.69 
control group: 
mean = 2.19 
p < 0.00 
Days 5-9 N.E. N.D.P. N.E. 
Inflammation (VAS) Days 1-9 N.E. N.D.P. N.E. 
Bleeding Days 1-9 N.E. N.D.P. N.E. 
Numbness Days 1-9 N.E. N.D.P. N.E. 
Temperature Days 1-9 N.E. N.D.P. N.E. 
Dehiscence Days 1-9 N.E. N.D.P. N.E. 
Variations in healing 
Day 3 N.E. N.E. 
PRP group: mean 
= 2.52  
control group: 
mean =4.07 
p<0.00 
Day 7 N.E. N.E. 
PRP group: mean 
= 0.66 
control group: 
mean = 0.95 
p < 0.00 
Incidence of alveolar 
osteitis  
N.E. N.E. 
4 cases in PRP 
group
18 cases in 
control group 
 p < 0.05 
Radiological bone density 
1 week N.E. N.D.P. N.E. 
2 weeks N.E. N.D.P. N.E. 
3 weeks N.E. N.D.P. N.E. 
4 weeks N.E. N.D.P. N.E. 
6 weeks N.E. N.D.P. N.E. 
8 weeks N.E. N.D.P. N.E. 
12 weeks N.E. N.D.P. N.E. 
16 weeks N.E. N.D.P. N.E. 
20 weeks N.E. N.D.P. N.E. 
24 weeks N.E. N.D.P. N.E. 
Media N.E. N.D.P. N.E. 
Osteoblast activity ratio 
1 week 
PRP group 
(2.61±0.53)
 control group 
(2.51±0.46) 
p> 0.05 
N.E. N.E. 
4 weeks 
PRP group 
(3.88±0.51)
 control group 
(3.61±0.44) 
P > 0.05 
N.E. N.E. 
Table 2. Results of studies included for analysis. (VAS = visual analogue scale; N.E. = not evaluated; N.D.P. = no data 
provided; PRP = platelet-rich plasma).
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eruption and without medical antecedents. 
Two tubes of 4.5 ml of blood were obtained with so-
dium citrate as anticoagulant. These were centrifuged 
for 10 minutes at 1150 g. The plasma was aspirated with 
a pipette, 3mm above and 2 mm below the interface 
between plasma and the red blood cell layer. Extraction 
of the lower third molars was performed, after which 
Gelfoam® was applied to a control group and Gelfoam® 
together with PRP to the study group. 
The study measured pain, inflammation, bleeding and 
temperature perceived by the patient, using a visual 
analogue scale nine days after surgery. No statistically 
significant differences were observed between the PRP 
group and the control group for any of the parameters 
analyzed. 
The study also evaluated dehiscence, bleeding, inflam-
mation and intraoral swelling perceived by an observer. 
A significant difference was observed in favor of PRP 
in relation to facial swelling. 
Digital periapical radiographs were made using VinWix 
Pro® software to determine bone density by means of 
gray scales. The mean radiological bone density was 
significantly greater in the group treated with PRP than 
in the control group (Student t test for paired samples: 
p<0.05).
Haraji et al. (12) set out to evaluate the prophylactic 
effect of PRP against alveolar osteitis, as well as its 
effect on pain management and the acceleration of the 
healing process. Forty patients were selected with bi-
lateral maxillary or mandibular third molars that pre-
sented similar levels of surgical difficulty and similar 
risk factors for alveolar osteitis: antecedents of perico-
ronaritis, treatment with oral contraceptives, smoking, 
bruxism or antecedents of dry alveolitis. 
10 ml. of blood were extracted in 1 ml tubes with so-
dium citrate at 3.8% as anticoagulant and centrifuged at 
460 g for 8 minutes. The portion of platelet-rich plasma 
was separated from the red blood and calcium chloride 
was added (0.05 ml. per ml of plasma). It was placed in 
an oven and heated at 37º for 5-8 minutes. 
After surgery, pain was evaluated by means of a visual 
analogue scale; healing was evaluated by means of ob-
servation of coagulate degeneration, wound dehiscence 
with suppuration, wound dehiscence without suppura-
tion (or non-healing). It was found that the intensity of 
post-operative pain was significantly less (p<0.00) and 
healing better (p<0.00) in the PRP group than in the 
control group. Incidence of post-operative alveolar os-
teitis on the side treated with PRP was significantly less 
(p<0.05) than on the conlateral side. 
Discussion
Platelet-rich plasma is used in a variety of clinical si-
tuations in the field of oral surgery, ranging from fi-
lling post-extraction alveoli to more complex surgery 
involving bone regeneration or sinus elevation (17-19). 
It is claimed that its use reduces pain and inflammation, 
accelerates the epithelialization of soft tissues and pro-
motes bone regeneration (20-21). The objective of this 
systematic literature review was to analyze the scien-
tific evidence available for PRP application in retained 
lower third molar surgery. 
Although there are many authors who extol the virtues 
of PRP use, there are few randomized clinical trials that 
have studied this topic. The present review could only 
Fig. 1. Flow diagram of randomized clinical trial selection process. 
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find seven clinical trials on the subject, of which four 
failed to meet Jadad criteria (13) for avoiding bias. 
The three remaining studies included for review - Gür-
büzer et al. (10), Rutkowski et al. (11), and Haraji et al. 
(12) - did not present any bias in relation to the clinical 
trial procedure, but two did present problems when it 
came to communicating the results. 
Haraji et al. (12) affirm that pain and inflammation le-
vels in the study group treated with PRP were lower 
than in the control group with statistically significant 
difference (p<0.00). However, the article did not include 
any values (mean, standard deviation or any numeric 
value) deriving from the trial. This article also deter-
mined the incidence of osteitis but failed to specify the 
method employed for its diagnosis. Furthermore, 80 
third molar extractions were performed – 40 maxillary 
and 40 mandibular – all of which were included in the 
results. This represents an important fault in methodo-
logy, given that, from a clinical point of view, the post-
operative conditions of a lower third molar cannot be 
compared with those of an upper third molar. 
Similarly, Rutkowski et al. (11) state that there were no 
differences between groups for the incidence of pain but 
a statistically significant reduction in inflammation in 
the PRP group. They found differences in the degree of 
ossification using digital radiography in favor of PRP. 
However, they fail to provide objective data for any of 
the variables studied and limit their results to the statis-
tical analysis applied to generate p-values. In addition, 
the patient sample was small, only six patients and twel-
ve lower third molars. As these two published studies 
failed to provide any data on pain or inflammation, and 
furthermore, their sample sizes were small, it is impos-
sible to carry a synthesis of these results by means of 
meta-analysis. 
The third clinical trial included for analysis, published 
by Gürbüzer et al. (13), measured osteoblast activity one 
week and four weeks after surgery. The study does com-
municate the results clearly but fails to find statistically 
significant differences between groups. No other study 
of this type can be found that would allow a comparison 
with these results. 
Another feature of the trials was the method employed 
for obtaining the platelet concentrate. None of the stu-
dies analyzed used the same method, a key factor gi-
ven that the concentration of growth factors will differ 
depending on the method used. It is even possible that 
some of the less rigorous protocols may have allowed 
the inclusion of red cells or white cells, which would 
produce a stronger inflammatory response than expec-
ted (11). 
Recently, the Spanish Agency of Medicines and Medi-
cal Products has published a report that considers PRP 
application a medication fit for human use. Authoriza-
tion of any medication implies that it meets the required 
criteria of quality, safety and efficacy. However, the re-
port states that clinical trials of sufficient quality are yet 
to be carried out before firm conclusions can be drawn 
as to its application and urges researchers to carry out 
clinical trials of adequate design in order to establish an 
adequate body of evidence for each pathology, type of 
PRP and application (Alonso C, Baró F, Blanquer M, de 
Felipe P, Fernández ME, Gómez-Chacón C, et al. IN-
FORME/ V1/23052013, Spanish Agency of Medicines 
and Medical Products on the use of platelet-rich plas-
ma, Ministry of Health, Social Services and Equality, 
available at: http://www.aemps.gob.es/vigilancia/medi-
camentosUsoHumano/docs/notificacion-SRA.pdf.).
When the Grade system guidelines were applied (14), 
the quality of published evidence for PRP application 
in lower third molar post-extraction alveoli was found 
to be poor and so recommendations for its clinical use 
cannot be made. 
Clearly, randomized clinical studies are needed that in-
vestigate the safety and efficacy of PRP post-operative 
treatments for lower third molar alveoli and compa-
re PRP applications with a placebo. Result variables 
should include its influence on pain, inflammation and 
trismus, bone and soft tissue healing and reduction of 
the periodontal sac distal of the adjacent second molar. 
Publication of the results of such trials should follow the 
Consort Declaration guidelines (22) in order to ensure 
the external validity of the results obtained. 
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